Ian Baguley
NSW, Australia · RMSANZ Member (Ordinary Membership) · FAFRM
Institution(s): AU
MM 1 - Metropolitan(Postcode: 2006)
Click a bar to filter publications by year
| Collaborator | Shared Pubs | Profile |
|---|---|---|
| Hannah Barden | 17 | View |
| Roxana Heriseanu | 11 | View |
| John Olver | 5 | View |
| Edwin Luk | 2 | View |
| Rachael Nunan | 2 | View |
| Gerard Weber | 2 | View |
| Peter Harradine | 2 | View |
| Anuka Parapuram | 1 | View |
| Barry Rawicki | 1 | View |
| Assoc Prof Anupam Datta Gupta | 1 | View |
| Anupam Datta Gupta | 1 | View |
| Dr Jenson Chun Sum Mak | 1 | View |
| Stephen de Graaff | 1 | View |
| Dr Stephen De Graaff | 1 | View |
| James Middleton | 1 | View |
| Helen Redmond | 1 | View |
| John Estell | 1 | View |
| Steven Faux | 1 | View |
| Senen Gonzalez | 1 | View |
| Mary Galea | 1 | View |
| Jane Wu | 1 | View |
| Sophia Lahz | 1 | View |
Objective measurement of muscle co-contraction pre-and post-Botulinum Toxin-A injection in adults with focal spasticity
Conditions: Stroke, Traumatic Brain Injuries, Acquired Brain Injuries, Cerebral Palsy, Multiple Sclerosis
Sponsor: A/Prof Ian Baguley
Funded by: Abbvie Pty Ltd
Statement of the Rehabilitation Medicine Society of Australia and New Zealand for the therapeutic use of botulinum toxin A in spasticity management
University of Adelaide · 2024
Paroxysmal sympathetic hyperactivity: the storm after acute brain injury
European Commission · 2017(602150)
Paroxysmal sympathetic hyperactivity: the storm after acute brain injury
National Institute for Health and Care Research · 2017(602150)
Efficacy and safety of abobotulinumtoxinA in spastic lower limb
Univerzita Karlova v Praze · 2017
Efficacy and safety of abobotulinumtoxinA in spastic lower limb
Uniwersytet Jagielloński Collegium Medicum · 2017
Efficacy and safety of abobotulinumtoxinA in spastic lower limb
Grantová Agentura České Republiky · 2017
Efficacy and safety of abobotulinumtoxinA in spastic lower limb
Ipsen · 2017
Efficacy and safety of abobotulinumtoxinA in spastic lower limb
Allergan · 2017
Efficacy and safety of abobotulinumtoxinA in spastic lower limb
Wake Forest School of Medicine · 2017
Efficacy and safety of abobotulinumtoxinA in spastic lower limb
lékařská fakulta Univerzity Karlovy · 2017
A50232043770000-0001-5650-3705